Effect of a proton pump inhibitor (omeprazole, Prilosec) on imatinib mesylate (Gleevec) pharmacokinetics in healthy volunteers (CSTI571BUS258)
Latest Information Update: 08 Dec 2015
At a glance
- Drugs Imatinib (Primary) ; Omeprazole
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Dermatofibrosarcoma; Gastrointestinal stromal tumours; Malignant melanoma; Precursor cell lymphoblastic leukaemia-lymphoma; Prostate cancer
- Focus Pharmacokinetics
- 09 Sep 2009 Actual end date (1 Aug 2009) added as reported by ClinicalTrials.gov
- 09 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 15 Feb 2008 The expected completion date for this trial is now 1 Dec 2008 as reported by ClinicalTrials.gov.